Key result
Akt activation confers cardioprotection after transient ischemia by limiting cardiomyocyte death and enhancing surviving cell function.
Why the study?
Akt activation may provide cardioprotection after transient ischemia by inhibiting cardiomyocyte death and improving surviving cardiomyocyte function.
Does Akt activation preserve cardiac function and prevent injury after transient cardiac ischemia in vivo?
Does Akt activation preserve cardiac function and prevent injury after transient cardiac ischemia in vivo?
Akt activation provides cardioprotection after transient ischemia by reducing cell death and improving function, highlighting it as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Akt activation merits further study as cardioprotective strategy; leaves open translation to human transient ischemia.
Akt activation exerts a powerful cardioprotective effect after transient ischemia that probably reflects its ability to both inhibit cardiomyocyte death and improve function of surviving cardiomyocytes. Akt may represent an important nodal target for therapy in ischemic and other heart disease.
No takes yet. Share an insight, caveat, or question.
Matsui et al. (2001) studied this question. Akt activation provides powerful cardioprotection after transient ischemia by inhibiting cardiomyocyte death and improving the function of surviving cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: